On February 18th, International Business Machines (IBM) declared that the company is planning to acquire ‘Truven Health Analytics’, a provider of healthcare data, analytics and consulting services, for USD 2.6 billion.
John Kelly (IBM senior vice president, cognitive solutions and research) said :
“This is such a rich data set. This is going to be a goldmine of insights.”
“Our goal was to enter the healthcare industry in a big way and try to be a contributor to better outcomes at lower costs”
Reportedly, it is IBM’s fourth major health-related acquisition since the company launched the Watson Health unit in April 2015.
In addition, IBM told that after the expected close of the Truven acquisition later this year, its cloud-based system will abode health-related data, depicting around 300 million patient lives. Furthermore, The Truven data will be integrated with Watson’s data, which will be used to identify health cost savings, improve healthcare outcomes and fight fraud.
The general manager for Watson Health, Deborah DiSanzo, told :
“With this acquisition, IBM will be the world’s leading health data, analytics and insights company, and the only one that can deliver the unique cognitive capabilities of the Watson platform”
As per sources, Truven, an firm based in Ann Arbor, Michigan, has more than 8,000 clients including hospitals, doctors, employers and government agencies and Its brands include 100 Top Hospitals, Action OI, Advantage Suite, CareDiscovery, MarketScan, Micromedex, and Simpler.
Truven was previously owned by Veritas Capital Management Fund LLC from Thomson Reuters Corp for $1.25 billion in the year 2012.
Source : Forbes